To provide timely, complementary evidence, we conducted a comparison of tirzepatide and semaglutide in patients at low, moderate and high cardiovascular risk who were diagnosed with obesity and type 2 diabetes and subgroups with specific cardiovascular conditions
At his more casual concepts all over the region, people are spending less on average, he said, and about the same at the higher-end spots
Tirzepatide may be more appropriate for patients with type 2 diabetes, insulin resistance, or those requiring stronger hormonal regulation for appetite and blood sugar control
Drugdrug interactions (DDIs)
The right approach is if youre going to cover the benefits, then lets make it as successful as possible and lets also help mitigate the friction and confusion that is out there. What are GLP-1s and how do they work
It is also important to understand that stopping treatment suddenly without maintaining lifestyle changes may contribute to weight regain in some individuals